Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine as adjunctive therapy in children with ADHD: double-blind randomized placebo-controlled study
IRCT20200427047221N1Phase 3Completed
- Sponsor
- Zanjan University of Medical Sciences
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in attention deficit hyperactivity disorder (ADHD) comparing Memantine adjunctive therapy with Placebo adjunctive therapy (2 arms). Started Jun 2020; status: completed.
02
Drugs
memantine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on IRCT20200427047221N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200427047221N1.